Febrivac DIST, liofilizatas ir skiediklis injekcinei suspensijai audinėms ir šeškams
Febrivac DIST, liofilizatas ir skiediklis injekcinei suspensijai audinėms ir šeškams
Authorised
- Canine distemper virus, strain Lederle D84/1, Live
Product identification
Medicine name:
Febrivac DIST, liofilizatas ir skiediklis injekcinei suspensijai audinėms ir šeškams
Active substance:
- Canine distemper virus, strain Lederle D84/1, Live
Target species:
-
Mink
-
Ferret
Route of administration:
-
Subcutaneous use
-
Intramuscular use
Product details
Active substance and strength:
-
Canine distemper virus, strain Lederle D84/1, Live5011.87/50% tissue culture infectious dose1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI20CD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- IDT Biologika GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- IDT Biologika GmbH
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/01/1332/001-003
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
RV1332.pdf
Lithuanian (PDF)
Download Published on: 9/06/2022
Updated on: 10/06/2022
